A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses

Imagem de Miniatura
Arquivos
art_SOUZA_A_novel_hepatitis_B_virus_species_discovered_in_2018.PDF (1.92 MB)
Citações na Scopus
47
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
SOUZA, Breno Frederico de Carvalho Dominguez
KOENIG, Alexander
RASCHE, Andrea
CARNEIRO, Ianei de Oliveira
STEPHAN, Nora
CORMAN, Victor Max
ROPPERT, Pia Luise
GOLDMANN, Nora
KEPPER, Ramona
MUELLER, Simon Franz
Citação
JOURNAL OF HEPATOLOGY, v.68, n.6, p.1114-1122, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background & Aims:All known hepatitis B virus (HBV) genotypes occur in humans and hominoid Old World non-human primates (NHPs). The divergent woolly monkey HBV (WMHBV) forms another orthohepadnavirus species. The evolutionary origins of HBV are unclear. Methods: We analysed sera from 124 Brazilian monkeys collected during 2012-2016 for hepadnaviruses using molecular and serological tools, and conducted evolutionary analyses. Results: We identified a novel orthohepadnavirus species in capuchin monkeys (capuchin monkey hepatitis B virus [CMHBV]). We found CMHBV-specific antibodies in five animals and high CMHBV concentrations in one animal. Noninflammatory, probably chronic infection was consistent with an intact preCore domain, low genetic variability, core deletions in deep sequencing, and no elevated liver enzymes. Cross-reactivity of antisera against surface antigens suggested antigenic relatedness of HBV, CMHBV, and WMHBV. Infection-determining CMHBV surface peptides bound to the human HBV receptor (human sodium taurocholate co-transporting polypeptide), but preferentially interacted with the capuchin monkey receptor homologue. CMHBV and WMHBV pseudo-types infected human hepatoma cells via the human sodium tralised by HBV vaccine-derived antibodies, suggesting that cross-species infections may be possible. Ancestral state reconstructions and sequence distance comparisons associated HBV with humans, whereas primate hepadnaviruses as a whole were projected to NHP ancestors. Co-phylogenetic analyses yielded evidence for co-speciation of hepadnaviruses and New World NHP. Bayesian hypothesis testing yielded strong support for an association of the HBV stem lineage with hominoid ancestors. Neither CMHBV nor WMHBV was likely the ancestor of the divergent human HBV genotypes found in American natives. Conclusions: Our data suggest ancestral co-speciation of hepadnaviruses and NHP, and an Old World origin of the divergent HBV genotypes FAH. The identification of a novel primate hepadnavirus offers new perspectives for urgently needed animal models of chronic hepatitis B. Lay summary: The origins of HBV are unclear. The new orthohepadnavirus species from Brazilian capuchin monkeys resembled HBV in elicited infection patterns and could infect human liver cells using the same receptor as HBV. Evolutionary analyses suggested that primate HBV-related viruses might have emerged in African ancestors of New World monkeys millions of years ago. HBV was associated with hominoid primates, including humans and apes, suggesting evolutionary origins of HBV before the formation of modern humans. HBV genotypes F/H found in American natives were divergent from those found in American monkeys, and likely introduced along prehistoric human migration. Our results elucidate the evolutionary origins and dispersal of primate HBV, identify a new orthohepadnavirus reservoir, and enable new perspectives for animal models of hepatitis B. (C) 2018 European Association for the Study of the Liver.
Palavras-chave
Hepatitis B virus, Viral evolution, New World, Primate, Human dispersal
URI
https://observatorio.fm.usp.br/handle/OPI/27144
Referências
  1. Alfaro JWL, 2014, AM J PRIMATOL, V76, P705, DOI 10.1002/ajp.22269
  2. Alter HJ, 2012, J HEPATOL, V57, P715, DOI [10.1016/j.jhep.2012.05.021, 10.1016/j.jhep.2012.06.032]
  3. Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599
  4. Balbuena JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061048
  5. Aragri M, 2016, J INFECT DIS, V213, P1897, DOI 10.1093/infdis/jiw049
  6. Bar-Gal GK, 2012, HEPATOLOGY, V56, P1671, DOI 10.1002/hep.25852
  7. Bertoletti A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00441
  8. Blitz L, 1998, J CLIN MICROBIOL, V36, P648
  9. Bond M, 2015, NATURE, V520, P538, DOI 10.1038/nature14120
  10. Botta A, 2000, VIROLOGY, V277, P226, DOI 10.1006/viro.1999.0127
  11. Bukh J, 2013, HEPATOLOGY, V58, P1533, DOI 10.1002/hep.26560
  12. Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284
  13. Drexler JF, 2013, P NATL ACAD SCI USA, V110, P16151, DOI 10.1073/pnas.1308049110
  14. Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
  15. Dupinay T, 2013, HEPATOLOGY, V58, P1610, DOI 10.1002/hep.26428
  16. Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z
  17. Foley NM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0140
  18. Fragaszy DM, 1998, AM J PRIMATOL, V44, P197, DOI 10.1002/(SICI)1098-2345(1998)44:3<197::AID-AJP2>3.0.CO;2-R
  19. Gomez-Robles A, 2017, P NATL ACAD SCI USA, V114, P468, DOI 10.1073/pnas.1608798114
  20. Grethe S, 2000, J VIROL, V74, P5377, DOI 10.1128/JVI.74.11.5377-5381.2000
  21. Hopkins ME, 2007, DIVERS DISTRIB, V13, P561, DOI 10.1111/j.1472-4642.2007.00364.x
  22. Houle A, 1999, AM J PHYS ANTHROPOL, V109, P541, DOI 10.1002/(SICI)1096-8644(199908)109:4<541::AID-AJPA9>3.0.CO;2-N
  23. KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
  24. Kierulff MCM, 2015, SAPAJUS XANTHOSTERNO, DOI 10.2305/IUCN.UK.2015-1.RLTS.T4074A70615251.en
  25. Konig A, 2014, J HEPATOL, V61, P867, DOI 10.1016/j.jhep.2014.05.018
  26. KUNTZ RE, 1971, EXP PARASITOL, V29, P33, DOI 10.1016/0014-4894(71)90007-5
  27. Lanford RE, 1998, P NATL ACAD SCI USA, V95, P5757, DOI 10.1073/pnas.95.10.5757
  28. Lauber C, 2017, CELL HOST MICROBE, V22, P387, DOI 10.1016/j.chom.2017.07.019
  29. Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734
  30. Lempp FA, 2017, HEPATOLOGY, V66, P703, DOI 10.1002/hep.29112
  31. Lin YY, 2015, J VIROL, V89, P3512, DOI 10.1128/JVI.03131-14
  32. Littlejohn M, 2016, COLD SPRING HARB PER, V6, P1
  33. Makuwa M, 2006, J MED PRIMATOL, V35, P384, DOI 10.1111/j.1600-0684.2006.00163.x
  34. Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60
  35. Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938
  36. Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
  37. NI YH, 1993, J HEPATOL, V17, P150, DOI 10.1016/S0168-8278(05)80030-3
  38. Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347
  39. Nunez H, 2008, J MED PRIMATOL, V37, P12, DOI 10.1111/j.1600-0684.2007.00215.x
  40. Paraskevis D, 2015, MOL PHYLOGENET EVOL, V93, P44, DOI 10.1016/j.ympev.2015.07.010
  41. Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079
  42. Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152
  43. Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619
  44. RABIN H, 1975, J NATL CANCER I, V54, P673
  45. RADZIWILL G, 1990, J VIROL, V64, P613
  46. Rasche A, 2016, CURR OPIN VIROL, V16, P86, DOI 10.1016/j.coviro.2016.01.015
  47. Shouval D, 2015, MED MICROBIOL IMMUN, V204, P57, DOI 10.1007/s00430-014-0374-x
  48. Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693
  49. Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521
  50. Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644
  51. Tacke F, 2007, J CLIN VIROL, V38, P353, DOI 10.1016/j.jcv.2006.12.024
  52. Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
  53. Tian YJ, 2016, IMMUNITY, V44, P1204, DOI 10.1016/j.immuni.2016.04.008
  54. Torres LB, 2010, AM J PRIMATOL, V72, P1055, DOI 10.1002/ajp.20864
  55. Tsubota A, 1998, J MED VIROL, V56, P287, DOI 10.1002/(SICI)1096-9071(199812)56:4<287::AID-JMV1>3.0.CO;2-P
  56. Wen WH, 2011, HEPATOLOGY, V53, P429, DOI 10.1002/hep.24061
  57. Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - ODS/03